Clinical Technologies

INSIGHTS ON CLINICAL TRIAL TECHNOLOGIES

Rapid Study Design With The Sculptor Portal
Accelerate your eCOA assessment design to streamline UAT, mid-study updates, and protocol amendments effortlessly.
The New Reality Of Clinical Trial Payment Workflows
Outdated trial payment processes create costly delays. Explore strategies for centralized financial management, participant reimbursement, and improved study execution.
Who Decides? Navigating AI Governance in Clinical Research
AI in clinical research poses governance challenges. Clear ownership, consistent policies, and aligned teams help manage risk, ensure compliance, and drive responsible innovation in complex trials.
Your IRB, Simplified: Fast, Friendly, And Focused
IRB approval does not have to be defined by delays or confusion. Learn how expert guidance, regulatory support, and modern technology can help research teams move forward with greater efficiency.

Should Sponsors Provide Source Document Templates?
12/9/2025

Here, we debate sponsor-provided source document templates, weighing regulatory guidance, compliance risks, and operational impacts for smarter clinical trial documentation decisions.
The Role Of EDC In Real-Time Decision-Making During Adaptive Trials
10/9/2025

Adaptive clinical trials are redefining how research evolves, relying on the ability to capture, clean, and act on data the moment it’s generated.
Parkinson's Disease: Leveraging Wearable DHTs
10/22/2024

Wearable DHTs offer a solution to the challenges of measuring Parkinson's disease in clinical trials. Discover how these technologies can improve outcome measures and accelerate drug development.
AI, Virtual Participants, and the Evolving FDA Regulatory Landscape
5/27/2026

Understanding emerging requirements around transparency, risk, and governance is essential for responsibly advancing AI-driven innovation in regulated environments.
AI in Pharma: Benefits, Risks, And The Road Ahead
10/23/2024

How could leveraging AI technologies, including machine learning (ML) and generative AI (GenAI), enable your company to streamline processes from drug discovery to post-launch?

More Insights On Clinical Trial Technologies

CLINICAL TRIAL TECHNOLOGY SOLUTIONS

AI-Powered Workflows: Accelerating Trial Execution
What can 22,000 people with an AI-mindset accomplish?

Speed without shortcuts

AI in clinical development at Parexel enables our teams to surface predictive insights at every stage, reducing protocol risk, study delays, and costly trial amendments.

Parexel's approach to AI in clinical development is built on the Precision Pathway, a strategic operating model that embeds AI across the full trial lifecycle. AI empowers our teams at critical decision points to:
1. Simplify complex tasks to accelerate timelines: AI capabilities are delivering up to 50% cycle time reductions in IND submission generation.
2. Apply insights with agility to enable better decision-making
3. Enhance data handling to drive first-time quality through content generation and workflow automation
IQVIA Integrated Complete Consent IRT eCOA

See how integrated eConsent, IRT, and eCOA work together to improve study quality, accelerate decision making, and reduce site and sponsor burden.
IQVIA's Integrated IRT eCOA Platform

Improve study quality, accelerate decision making, and reduce site and sponsor burden by using IQVIA’s integrated Interactive Response Technology and electronic Clinical Outcome Assessment solution.
De-Risk Randomization With The Endpoint Biostatistical Approach

With over 15 years of RTSM experience, high-touch quality management, and forward-thinking technology, our solutions enhance trial speed, accuracy, and operational efficiency.
Connected Solutions For Self-Injection

From enabling connected clinical trials to supporting digital therapy management, our solutions help improve clinical trial operational efficiency and data quality, strengthen commercial success, and empower patients to self-manage their therapy.